Schimmelpennink Evert B.
Insider CIK 1713795 · IBIO Director · PFNX See Remarks, Director · LENZ President, CEO and Secretary, Director · CTNM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CTNM Contineum Therapeutics, In | A Award deriv | 2026-06-26 | 2026-06-26 | 19,000 | — | $0 | 19,000 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | P Buy | 2026-03-27 | 2026-03-30 | 28,089 | $8.95 | $251.4K | 77,289 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 358,100 | — | $0 | 358,100 | SEC↗ |
| IBIO iBio, Inc. | A Award deriv | 2025-11-20 | 2025-11-24 | 13,500 | — | $0 | 13,500 | SEC↗ |
| CTNM Contineum Therapeutics, In | A Award deriv | 2025-06-26 | 2025-06-26 | 14,750 | — | $0 | 14,750 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | M Exercise deriv | 2025-03-07 | 2025-03-07 | 4,200 | — | $0 | 337,906 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | M Exercise | 2025-03-07 | 2025-03-07 | 4,200 | $1.04 | $4.4K | 49,200 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | A Award deriv | 2025-01-09 | 2025-01-13 | 279,100 | — | $0 | 279,100 | SEC↗ |
| IBIO iBio, Inc. | A Award deriv | 2024-11-21 | 2024-11-25 | 18,900 | — | $0 | 18,900 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | M Exercise deriv | 2024-07-22 | 2024-07-23 | 45,000 | — | $0 | 342,106 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | M Exercise | 2024-07-22 | 2024-07-23 | 45,000 | $1.04 | $46.8K | 45,000 | SEC↗ |
| CTNM Contineum Therapeutics, In | A Award deriv | 2024-05-24 | 2024-05-29 | 29,500 | — | $0 | 29,500 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | A Award deriv | 2024-03-21 | 2024-03-25 | 475,000 | — | $0 | 475,000 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | A Award deriv | 2024-03-21 | 2024-03-25 | 387,106 | — | $0 | 387,106 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | A Award deriv | 2024-03-21 | 2024-03-25 | 82,723 | — | $0 | 82,723 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | A Award deriv | 2024-03-21 | 2024-03-25 | 315,864 | — | $0 | 315,864 | SEC↗ |
| IBIO iBio, Inc. | A Award deriv | 2021-12-09 | 2021-12-13 | 109,000 | — | $0 | 109,000 | SEC↗ |
| IBIO iBio, Inc. | A Award deriv | 2021-06-07 | 2021-06-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PFNX Pfenex Inc. | U Tender deriv | 2020-10-01 | 2020-10-05 | 300,000 | — | $0 | 0 | SEC↗ |
| PFNX Pfenex Inc. | U Tender deriv | 2020-10-01 | 2020-10-05 | 225,000 | — | $0 | 0 | SEC↗ |
| PFNX Pfenex Inc. | U Tender deriv | 2020-10-01 | 2020-10-05 | 313,710 | — | $0 | 0 | SEC↗ |
| PFNX Pfenex Inc. | U Tender deriv | 2020-10-01 | 2020-10-05 | 195,062 | — | $0 | 0 | SEC↗ |
| PFNX Pfenex Inc. | U Tender deriv | 2020-10-01 | 2020-10-05 | 36,290 | — | $0 | 0 | SEC↗ |
| PFNX Pfenex Inc. | U Tender | 2020-10-01 | 2020-10-05 | 10,000 | — | $0 | 0 | SEC↗ |
| PFNX Pfenex Inc. | U Tender | 2020-10-01 | 2020-10-05 | 16,658 | — | $0 | 0 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2020-02-03 | 2020-02-03 | 225,000 | — | $0 | 225,000 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2019-02-01 | 2019-02-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| PFNX Pfenex Inc. | P Buy | 2018-09-11 | 2018-09-13 | 500 | $5.01 | $2.5K | 26,658 | SEC↗ |
| PFNX Pfenex Inc. | P Buy | 2018-09-11 | 2018-09-13 | 9,500 | $5.04 | $47.9K | 26,158 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2018-02-01 | 2018-02-02 | 195,062 | — | $0 | 195,062 | SEC↗ |
| PFNX Pfenex Inc. | A Award | 2018-02-01 | 2018-02-02 | 27,894 | — | $0 | 27,894 | SEC↗ |
| PFNX Pfenex Inc. | F Tax w/h | 2018-02-01 | 2018-02-02 | 11,236 | $3.38 | $38.0K | 16,658 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2017-09-01 | 2017-09-01 | 36,290 | — | $0 | 36,290 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2017-09-01 | 2017-09-01 | 313,710 | — | $0 | 313,710 | SEC↗ |